Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Gastroenterology and Hepatology

• Publication date

  2013-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cgh.2013.02.011PMID 23416328PMCID PMC4197011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review of article: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 by Katherine M. Flegal, PhD; Margaret D. Carroll, MSPH; Brian K. Kit, MD; Cynthia L. Ogden, PhD (JAMA 2012;307:491-7).

  2013cited by this paper
• Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

  2013cited by this paper
• Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits

  2011cited by this paper
• Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

  2011cited by this paper
• Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study

  2011cited by this paper
• Association of PNPLA3 with non‐alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study

  2011cited by this paper
• Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels

  2011cited by this paper
• Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis

  2011cited by this paper
• Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

  2010cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2008.

  2010cited by this paper
• New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

  2010cited by this paper
• NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study

  2009cited by this paper
• Six new loci associated with body mass index highlight a neuronal influence on body weight regulation

  2009cited by this paper
• Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests.

  2009cited by this paper
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

  2008cited by this paper
• Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.

  2008cited by this paper
• Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

  2008cited by this paper
• Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

  2007cited by this paper
• Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels

  2007cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.

  2003cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels

  2002cited by this paper
• American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease.

  2002cited by this paper
• Sonographic findings in type I glycogen storage disease

  2001cited by this paper
• Prevalence and ethnic differences in gallbladder disease in the United States.

  1999cited by this paper
• Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

  1998cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper
• Influence of Glycogen on Liver Density: Computed Tomography from a Metabolic Perspective

  1983cited by this paper
• Edinburgh Research Explorer Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution

  year unknowncited by this paper

• Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application

  2025cites this paper
• Advanced lung cancer inflammation index as a predictor of all-cause and cardiovascular mortality among patients with hypertension in the US

  2025cites this paper
• Prevalence of MASLD and fibrosis assessed by transient elastography in U.S. adolescents: insights from NHANES 2017-2023

  2025cites this paper
• Causal relationship between gut microbiota and pneumonia: a Mendelian randomization and retrospective case–control study

  2025cites this paper
• Impact of Change, Fluctuation, or Variability in Weight on the Risk of Nonalcoholic Fatty Liver Disease in General Population: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Autoimmune Thyroid Disease in the United States: Population Prevalence, Diagnosis Rates, and Trends.

  2025cites this paper
• Situational panorama of chronic liver diseases: A single-center experience at a University Hospital in northeast Mexico (1995-2019).

  2025cites this paper
• Polygenic Risk Score for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Narrative Review

  2025cites this paper
• Ppp1r3b is a metabolic switch that shifts hepatic energy storage from lipid to glycogen

  2025cites this paper
• Lower Frequency of PNPLA3 Polymorphism in West African Populations and Divergent Associations With Hepatocellular Carcinoma

  2025cites this paper
• Association of systemic immune-inflammation index (SII) with risk of psoriasis: a cross-sectional analysis of National Health and Nutrition Examination Survey 2011–2014

  2025cites this paper
• Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease

  2025cites this paper
• Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse

  2024cites this paper
• Non-linear association of sleep duration with osteoarthritis among U.S. middle-aged and older adults

  2024cites this paper
• A cross-sectional study on the relationship between dietary fiber and endometriosis risk based on NHANES 1999–2006

  2024cites this paper
• Mechanisms coupling lipid droplets to MASLD pathophysiology.

  2024cites this paper
• Gender-specific association between a lipid composite index and asthma among US adults: insights from a population-based study

  2024cites this paper
• Integrating PNPLA3 into clinical risk prediction

  2024cites this paper
• Association of systemic immune inflammatory index with obesity and abdominal obesity: A cross-sectional study from NHANES.

  2024cites this paper
• Genetic predisposition to metabolic dysfunction-associated fatty liver disease

  2024cites this paper
• Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases

  2024cites this paper
• The association between flavonoids intake and hypertension in U.S. adults: A cross‐sectional study from The National Health and Nutrition Examination Survey

  2024cites this paper
• RETRACTED ARTICLE: Changes in Blood Pressure is Associated with Bone Loss in US Adults: A Cross-Sectional Study from NHANES 2005–2018

  2024cites this paper
• Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: an updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018.

  2023cites this paper
• Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD

  2023cites this paper
• Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis

  2023cites this paper
• Factores de riesgo de la enfermedad hepática grasa asociada a disfunción metabólica en población hispano-mexicana

  2023cites this paper
• Examining genetic associations with hepatic steatosis in Mexican-origin adults

  2023cites this paper
• Waist circumference mediates the association between rs1260326 in GCKR gene and the odds of lean NAFLD

  2023cites this paper
• Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study

  2023cites this paper
• Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination Survey

  2023cites this paper
• PPP1R3B is a metabolic switch that shifts hepatic energy storage from lipid to glycogen

  2023cites this paper
• Plasma Metabolite Signatures in Male Carriers of Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Association between healthy eating index-2015 and abdominal aortic calcification among US Adults

  2023cites this paper
• Association of HSD17B13 and PNPLA3 with liver enzymes and fibrosis in Hispanic/Latino individuals of diverse genetic ancestries.

  2023cites this paper
• Frequency of the PNPLA3 rs738409 polymorphism and other genetic loci for liver disease in a Guatemalan adult population

  2022cites this paper
• Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review

  2022cites this paper
• The effect of total cholesterol/high-density lipoprotein cholesterol ratio on mortality risk in the general population

  2022cites this paper
• Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Update on genetics and epigenetics in metabolic associated fatty liver disease

  2022cites this paper
• En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH.

  2022cites this paper
• The development of the Metabolic-associated Fatty Liver Disease during pharmacotherapy of mental disorders - a review

  2022cites this paper
• Prediction of nonalcoholic fatty liver disease using anthropometry and body fat measures by sex and race/ethnicity in the United States

  2022cites this paper
• Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western China

  2022cites this paper
• Contribution of a genetic risk score to ethnic differences in fatty liver disease

  2022cites this paper
• Non-alcoholic Fatty Liver Disease prevalence in Latin America: A systematic review and meta-analysis.

  2022cites this paper
• Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients

  2021cites this paper
• The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

  2021cites this paper
• Poor Awareness of Liver Disease Among Adults With NAFLD in the United States

  2021cites this paper
• The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity

  2021influential citation
• Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors

  2021cites this paper
• Associations of Hydroxysteroid 17-beta Dehydrogenase 13 Variants with Liver Histology in Chinese Patients with Metabolic-associated Fatty Liver Disease

  2021cites this paper
• The effect of PNPLA3 polymorphism as gain in function mutation in the pathogenesis of non-alcoholic fatty liver disease

  2020cites this paper
• Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis.

  2020cites this paper
• Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population

  2020cites this paper
• Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants

  2020cites this paper
• Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis

  2020cites this paper
• Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease

  2020influential citation
• Fatty liver diseases, mechanisms, and potential therapeutic plant medicines.

  2020cites this paper
• Interaction between alcohol consumption and PNPLA3 variant in the prevalence of hepatic steatosis in the U.S. Population.

  2020cites this paper
• High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and Progression

  2020cites this paper
• Clinical Genomics of NAFLD

  2020cites this paper
• Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican-Americans: The GUARDIAN Consortium.

  2019cites this paper
• Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups.

  2019cites this paper
• High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.

  2019cites this paper
• Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes

  2019cites this paper
• Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity

  2019cites this paper
• Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population.

  2019cites this paper
• Alcoholic/Non-Alcoholic Digestive Diseases

  2019cites this paper
• Diabetes in Liver Disease

  2019cites this paper
• Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management.

  2019cites this paper
• The Importance of Amerindian Ancestry on Nonalcoholic Fatty Liver Disease in the Hispanic/Latino American Population.

  2019cites this paper
• Genetic variants that associate with cirrhosis have pleiotropic effects on human traits

  2019cites this paper
• PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease

  2019cites this paper
• Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004

  2019cites this paper
• Patatin‐Like Phospholipase Domain‐Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population

  2019cites this paper
• More Evidence for the Genetic Susceptibility of Mexican Population to Nonalcoholic Fatty Liver Disease through PNPLA3.

  2018cites this paper
• Title High frequency of the PNPLA 3 rs 738409 [ G ] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease Permalink

  2018cites this paper
• Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease.

  2018cites this paper
• Clinical workup of fatty liver for the primary care provider

  2018cites this paper
• Parental non‐alcoholic fatty liver disease increases risk of non‐alcoholic fatty liver disease in offspring

  2018cites this paper
• Recent research trends and updates on nonalcoholic fatty liver disease

  2018cites this paper
• A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis

  2018cites this paper
• Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption

  2018cites this paper
• Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease

  2018cites this paper
• Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014

  2018cites this paper
• Chronic liver diseases and the potential use of S-adenosyl-L-methionine as a hepatoprotector.

  2018cites this paper
• Assessing the Non-tumorous Liver: Implications for Patient Management and Surgical Therapy

  2018cites this paper
• The rs4686434 variant in the fetuin B (FETUB) locus is associated with intrahepatic triglyceride content in obese Chinese adults

  2018cites this paper
• Lawrence Berkeley National Laboratory Recent Work Title Relationship between genetic variation at PPP 1 R 3 B and levels of liver glycogen and triglyceride Permalink

  2018cites this paper
• Identification of molecular pathophysiological mechanismsof non-alcoholic fatty liver disease (NAFLD)

  2018cites this paper
• Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride

  2018cites this paper
• US National Health and Nutrition Examination Survey Arthritis Initiatives, Methodologies and Data.

  2018cites this paper
• High frequency of the PNPLA3 rs738409 [G] single‐nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease

  2018cites this paper
• Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease

  2018cites this paper
• Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression

  2017cites this paper
• Hepatic protein phosphatase 1 regulatory subunit 3B (Ppp1r3b) promotes hepatic glycogen synthesis and thereby regulates fasting energy homeostasis

  2017cites this paper
• A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains

  2017cites this paper
• Genome‐Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy

  2017cites this paper
• Interaction between obesity and the Hypoxia Inducible Factor 3 Alpha Subunit rs3826795 polymorphism in relation with plasma alanine aminotransferase

  2017cites this paper